Semaglutide vs Tirzepatide

The two leading GLP-1 weight loss medications compared head-to-head.

Weight LossGLP-1MetabolicUpdated March 2026
VS

Quick Verdict

Both are FDA-approved weight loss medications, but tirzepatide’s dual-mechanism (GIP + GLP-1) shows greater weight loss in trials. Semaglutide has a longer track record and more cardiovascular data.

Best for

Semaglutide

Proven weight loss with strong cardiovascular data. The established choice with the most long-term safety data.

Best for

Tirzepatide

Maximum weight loss potential. Dual-mechanism approach showing 20–25% weight loss in trials — the most effective option available.

Head-to-Head Comparison

Semaglutide
Tirzepatide
Full Name
Semaglutide (GLP-1 Receptor Agonist)
Tirzepatide (Dual GIP/GLP-1 Agonist)
Category
GLP-1 Receptor Agonist
Dual GIP/GLP-1 Receptor Agonist
Mechanism
Mimics GLP-1 hormone, slowing gastric emptying, increasing insulin secretion, and acting on brain appetite centers to reduce hunger and caloric intake.
Dual agonist targeting both GIP and GLP-1 receptors. Provides enhanced insulin sensitivity, greater appetite suppression, and improved glucose metabolism compared to single-receptor agonists.
Best For
  • • Weight loss (15–20% body weight)
  • • Appetite suppression
  • • Blood sugar regulation
  • • Cardiovascular risk reduction
  • • Maximum weight loss (20–25% body weight)
  • • Type 2 diabetes management
  • • Superior appetite control
  • • Metabolic syndrome
Evidence Level
Strong— FDA-approved, extensive Phase 3 trials (STEP, SELECT)
Strong— FDA-approved, SURMOUNT trials showing superior efficacy
Typical Dosing
0.25mg–2.4mg weekly (titrated)
Subcutaneous injection, once weekly
2.5mg–15mg weekly (titrated)
Subcutaneous injection, once weekly
Administration
Subcutaneous injection, once weekly
Subcutaneous injection, once weekly
Time to Effect
2–4 weeks for appetite; 12–16 weeks for significant weight loss
2–4 weeks for appetite; 12–20 weeks for significant weight loss
Side Effects
Nausea, vomiting, diarrhea (usually transient). Rare: pancreatitis.
Nausea, diarrhea, decreased appetite (usually transient). Similar to semaglutide.
Blood Test
Recommended (A1c, metabolic panel)
Recommended (A1c, metabolic panel)
Price Tier
$$$$
$$$$
ProtocolRx
✓ We offer this
✓ We offer this

Which One Should You Choose?

Choose Semaglutide if you...

  • ✓Want significant weight loss (15%+ body weight)
  • ✓Struggle with appetite and portion control
  • ✓Have type 2 diabetes or insulin resistance
  • ✓Want cardiovascular risk reduction
  • ✓Are okay with weekly injections

Choose Tirzepatide if you...

  • ✓Want maximum possible weight loss
  • ✓Have type 2 diabetes or severe insulin resistance
  • ✓Did not get adequate results from semaglutide alone
  • ✓Want dual-mechanism metabolic support
  • ✓Are okay with weekly injections

Not sure which is right for you?

Take our quiz and we'll recommend the right compounds for your specific goals and health profile.

Build Your Protocol →

Related Comparisons

Semaglutide vs Liraglutide→Tirzepatide vs Retatrutide→